NYXH

Nyxoah S.A. [NYXH] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

NYXH Stock Summary

In the News

NYXH Financial details

Company Rating
-
Market Cap
258.24M
Income
-43.21M
Revenue
4.35M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
146
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
-2.58
Forward P/E
-
PEG
-0.89
P/S
30.76
P/B
1.09
P/C
-
P/FCF
-2.08
Quick Ratio
5.32
Current Ratio
5.55
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.56
EPS next Y
-
EPS next Q
-
EPS this Y
28.1%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
86.89%
EPS Q/Q
40.74%
-
-
-
-
SMA20
-12.5%
SMA50
-
SMA100
-30%
Inst Own
-
Inst Trans
-
ROA
-34%
ROE
-39%
ROC
-0.36%
Gross Margin
64%
Oper. Margin
-1131%
Profit Margin
-1191%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.0-20.0
52W High
-63.38%
52W Low
+83.13%
RSI
40
Rel Volume
1.55
Avg Volume
58.81K
Volume
90.98K
Perf Week
-5.85%
Perf Month
-5.12%
Perf Quarter
-31.22%
Perf Half Y
-32.36%
-
-
-
-
Beta
0.477
-
-
Volatility
0.24%, 0.28%
Prev Close
2.88%
Price
7.325
Change
-2.2%

Something similar

Top by Market Cap
FB2A.DE
GOOG
FXAIX
3V64.DE
JPM
Same Sector
6678.T
SNCE
019175.KS
0QZU.L
CSUI
Same Price Range
ZPS.TO
002798.SZ
CPH.TO
1184.HK
AYA.TO
Similar Market Cap
SMLP
IQSI
CHR.TO
SDVRX
AXTI

Company Profile

Healthcare Medical - Instruments & Supplies
  • Volume Average 58.81K
  • Market Capitalization 258.24M
  • Employee 146
  • CEO Mr. Olivier Taelman
  • Headquarters Mont-Saint-Guibert,BE
  • IPO Date 2021-04-28
  • Website https://www.nyxoah.com

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.